288
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas

(Director) , , , , , , , & show all
Pages 897-911 | Published online: 16 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Simone Ferrero, Valerio Gaetano Vellone & Fabio Barra. (2018) Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids. Expert Opinion on Drug Metabolism & Toxicology 14:1, pages 107-116.
Read now
Emanuela Tafi, Carolina Scala, Umberto Leone Roberti Maggiore, Nicolò Bizzarri, Massimo Candiani, Pier Luigi Venturini & Simone Ferrero. (2015) Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids. Expert Opinion on Drug Safety 14:6, pages 965-977.
Read now
José Alberto Fonseca-Moutinho, Lígia Silva Barbosa, Daniel Gonçalves Torres & Sara Morgado Nunes. (2013) Abnormal uterine bleeding as a presenting symptom is related to multiple uterine leiomyoma: an ultrasound-based study. International Journal of Women's Health 5, pages 689-694.
Read now

Articles from other publishers (4)

Andrea S. Lukes, David Soper, Amanda Harrington, Vilma Sniukiene, Yifan Mo, Patrick Gillard & Lee Shulman. (2019) Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas. Obstetrics & Gynecology 133:5, pages 869-878.
Crossref
Mohamed Ali & Ayman Al-Hendy. (2017) Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids†. Biology of Reproduction 97:3, pages 337-352.
Crossref
Kristina Arendas & Nicholas A. Leyland. (2016) Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding. Journal of Obstetrics and Gynaecology Canada 38:1, pages 80-83.
Crossref
Jacques Donnez, Pablo Arriagada, Olivier Donnez & Marie-Madeleine Dolmans. (2015) Current management of myomas. Current Opinion in Obstetrics & Gynecology 27:6, pages 422-431.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.